[1]
A. Fathi, M. Vafaie, F. Amani, and N. Mohebbi, “Evaluation of Osveral efficacy in reducing ferritin levels in patients with thalassemia major”, Int J Basic Clin Pharmacol, vol. 6, no. 11, pp. 2556–2560, Oct. 2017.